Sign up for free.
Sirtex Medical is a leading medical technology company specializing in innovative solutions for the treatment of liver cancer. With over 20 years of industry experience, the company has established itself as an established market leader and supports healthcare professionals worldwide with state-of-the-art technologies to improve patient care.
Sirtex offers a comprehensive portfolio of medical devices for the treatment of liver diseases:
The company's flagship product is a revolutionary medical device for selective internal radiation therapy (SIRT), also known as radioembolization. These extremely small resin beads (approximately 32 micrometers in diameter) contain the radioactive element Yttrium-90 and are delivered directly into liver tumors. They use the unique blood supply of the liver to specifically concentrate radiation on tumors. The technology is approved for the treatment of inoperable metastatic liver tumors of primary colorectal cancer as well as hepatocellular carcinoma. Clinical studies have shown that SIR-Spheres® in combination with chemotherapy can improve tumor shrinkage and, in some cases, enable subsequent surgical removal.
An innovative system for the treatment of peripheral vascular bleeding and the first and only liquid embolic approved for this indication.
Sirtex also offers the INSYTE with SurePlan™ LiverY90 platform - a time-efficient tool for liver and tumor segmentation, deformable registration and post-treatment dosimetry that helps professionals with therapy planning and monitoring.
Sirtex's mission is to provide healthcare professionals with the necessary support and technology to effectively treat patients with liver cancer. The company's goal is to educate medical professionals and patients about the possibilities of products to improve clinical outcomes and quality of life.
The company offers Flexibility and Control for professionals to advance patient care. This is reflected in the development of customizable solutions that meet various clinical requirements.
Sirtex focuses on several specialized medical fields:
Sirtex operates internationally with locations in North America, Australia/New Zealand, Europe and Latin America. The company has specialized teams for clinical support, reimbursement management and technical service.
The company continuously invests in research and development to improve existing technologies and develop new treatment options. Scientific studies suggest that treatment with SIR-Spheres® can help patients feel better and live longer.
Sirtex provides extensive educational materials for patients and professionals to promote understanding of SIRT technology and to support patients in their decision-making.
Sirtex Medical is at the forefront of liver cancer treatment innovation and sets standards in interventional oncology. With its state-of-the-art products, extensive clinical experience and patient-centered approach, the company makes a significant contribution to improving treatment outcomes and positively impacting the lives of cancer patients.
